Assessment of physician behaviour regarding metabolic monitoring of patients treated with SEROQUEL® (quetiapine fumarate) Tablets and SEROQUEL® (quetiapine fumarate) Extended Release Tablets in selected countries in the European Union (EU)First published 01/02/2013 Last updated 02/04/2024 EU PAS number: EUPAS3287StudyFinalised